Skip to main content
Equibles

PANAGORA ASSET MANAGEMENT INC

Position in ENTA — Enanta Pharmaceuticals Inc

CIK 883677 Boston, MA
Back to ENTA Full portfolio

Position in ENTA

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$507,223
-$624,412 QoQ
Shares Held
34,789
-61.2% QoQ
Ownership
0.119%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 122 holders
Holding Since
Mar 2020
4 quarters on record
Voting authority Sole 9% Shared 0% None 91%

Common Shares in ENTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PANAGORA ASSET MANAGEMENT INC holds $623,499,718 across 77 Biotechnology names. ENTA ranks #59 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 175,291 $109,300,950
2 INCY
Incyte Corp
 881,889 $99,970,937
3 XENE
Xenon Pharmaceuticals Inc.
 664,031 $40,080,911
4 MIRM
Mirum Pharmaceuticals, Inc.
 337,461 $39,506,559
5 TVTX
Travere Therapeutics, Inc.
 490,724 $27,878,030
6 JAZZ
Jazz Pharmaceuticals plc
 104,935 $25,286,186
7 RLAY
Relay Therapeutics, Inc.
 1,291,182 $24,158,015
8 CLDX
Celldex Therapeutics, Inc.
 572,538 $21,304,138

All Filings in ENTA

Export CSV
4 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $507,223 34,789
2026-03-31 $1,131,635 89,599
2025-12-31 $1,056,432 66,990
2020-03-31 $57,293 1,114